Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCH 717454 in Relapsed Osteosarcoma or Ewing Sarcoma
2007-005341-38Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of robatumumab in osteosarcoma (OS), Ewing sarcoma, sponsored by Merck & Co.. Started Dec 2007; status: completed.
02
Drugs
robatumumab
03
Conditions
osteosarcoma (OS)Ewing sarcoma
Beyond the preview
Go deeper on 2007-005341-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005341-38.